^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    oNKord (inaleucel)

    i
    Associations
    News

    Trials

    Company:
    Glycostem, Korea Kolmar, Medac, Radboud University
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Natural Killer-cell Therapy for Acute Myeloid Leukemia (NK4AML) (NCT04347616)
    Phase 1/2
    Radboud University Medical Center
    Recruiting
    Last update posted :
    04/23/2024
    Initiation :
    12/03/2020
    Primary completion :
    09/01/2025
    Completion :
    09/01/2025
    IL2
    |
    cyclophosphamide • Proleukin (aldesleukin) • oNKord (inaleucel)
    Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients (INTRO) (NCT03539406)
    Phase 1
    Radboud University Medical Center
    Recruiting
    Last update posted :
    10/28/2022
    Initiation :
    06/04/2019
    Primary completion :
    05/01/2023
    Completion :
    10/01/2023
    MUC16
    |
    oNKord (inaleucel)